TGF-β induces the expression of the adaptor Ndfip1 to silence IL-4 production during iT reg cell differentiation

Nature Immunology

Volumn 13, Issue 1, 2012, Pages 77-85

  Beal, Allison M ^a   Ramos Hernández, Natalia ^b   Riling, Chris R ^b   Nowelsky, Erin A ^a   Oliver, Paula M ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ANTIGEN; INTERLEUKIN 4; PROTEIN NDFIP1; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR JUNB; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE E3 ITCH; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; FLOW CYTOMETRY; IMMUNOBLOTTING; INDUCIBLE REGULATORY T LYMPHOCYTE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SMALL INTESTINE; UPREGULATION;

ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; INTERLEUKIN-4; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN-PROTEIN LIGASES;

EID: 83855160777     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2154     Document Type: Article

References (50)

1. Bluestone, J.A. & Abbas, A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3, 253-257 (2003).
2. Curotto de Lafaille, M.A. & Lafaille, J.J. Natural and adaptive Foxp3+ regulatory T cells: more of the same or division of labor. Immunity 30, 626-635 (2009).
3. Brunkow, M.E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68-73 (2001).
4. Bennett, C.L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21 (2001).
5. Wildin, R.S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18-20 (2001).
6. Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
7. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
8. Khattri, R., Cox, T., Yasayko, S.A. & Ramsdell, F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4, 337-342 (2003).
9. Josefowicz, S.Z. & Rudensky, A.Y. Control of regulatory T cell lineage commitment and maintenance. Immunity 30, 616-625 (2009).
10. Malek, T.R. & Castro, I. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 33, 153-165 (2010).
11. Xu, L., Kitani, A. & Strober, W. Molecular mechanisms regulating TGF-beta-induced Foxp3 expression. Mucosal Immunol. 3, 230-238 (2010).
12. Sakaguchi, S., Wing, K. & Miyara, M. Regulatory T cells-a brief history and perpective. Eur. J. Immunol. 37, S116-S123 (2007).
13. Chen, W. et al. Conversion of peripheral CD4+CD25 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
14. Kretschmer, K. et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219-1227 (2005).
15. Apostolou, I. & von Boehmer, H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199, 1401-1408 (2004).
16. Fantini, M.C. et al. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25 T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172, 5149-5153 (2004).
17. Park, H.B., Paik, D.J., Jang, E., Hong, S. & Youn, J. Acquisition of anergic and suppressive activities in transforming growth factor-beta- costimulated CD4+CD25 T cells. Int. Immunol. 16, 1203 (2004).
18. Wan, Y.Y. & Flavell, R.A. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102, 5126-5131 (2005).
19. Dardalhon, V. et al. IL-4 inhibits TGF-β-induced Foxp3+ T cells, and together with TGF-β generates IL-9+ IL-10+ Foxp3? effector T cells. Nat. Immunol. 9, 1347-1355 (2008).
20. Gorelik, L., Fields, P.E. & Flavell, R.A. TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression. J. Immunol. 165, 4773-4777 (2000).
21. Tone, Y. et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9, 194-202 (2007).
22. Hefferan, T.E. et al. Overexpression of a nuclear protein, TIEG, mimics transforming growth factor-beta action in human osteoblast cells. J. Biol. Chem. 275, 20255-20259 (2000).
23. Venuprasad, K. et al. The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1. Nat. Immunol. 9, 245-253 (2008).
24. Cao, Z. et al. Kruppel-like factor KLF10 targets transforming growth factor-β to regulate CD4+CD25 T cells and T regulatory cells. J. Biol. Chem. 11, 24914-24924 (2009).
25. Oliver, P.M. et al. Ndfip1 protein promotes the function of Itch ubiquitin ligase to prevent T cell activation and T helper 2 cell-mediated inflammation. Immunity 25, 929-940 (2006).
26. Rooney, J.W., Hoey, T. & Glimcher, L.H. Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of murine IL-4 gene. Immunity 2, 473-483 (1995).
27. Li-Weber, M., Giasi, M. & Krammer, P.H. Involvement of Jun and Rel proteins in up-regulation of interleukin-4 gene activity by the T cell accessory molecule CD28. J. Biol. Chem. 273, 32460-32466 (1998).
28. H2 differentiation. Nat. Immunol. 3, 281-287 (2002).
29. Ramon, H.E. et al. The ubiquitin ligase adaptor Ndfip1 regulates T cell-mediated gastrointestinal inflammation and inflammatory bowel disease susceptibility. Mucosal Immunol. 4, 314-324 (2011).
30. Liu, Y. et al. A critical function for TGF-β signaling in the development of natural CD4+ CD25+Foxp3+ regulatory T cells. Nat. Immunol. 9, 632-640 (2008).
31. Fontenot, J.D., Dooley, J.L., Farr, A.G. & Rudensky, A.Y. Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202, 901-906 (2005).
32. Coombes, J.L. et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757-1764 (2007).
33. Sun, C.M. et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775-1785 (2007).
34. Siddiqui, K.R. & Powrie, F. CD103+ GALT DCs promote Foxp3+ regulatory T cells. Mucosal Immunol. 1 (suppl. 1), S34-S38 (2008).
35. Thornton, A.M. et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184, 3433-3441 (2010).
36. Verhagen, J. & Wraith, D.C. Comment on "Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells". J. Immunol. 185, 7129 (2010).
37. Thornton, A.M. & Shevach, E.M. Response to comment on "Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells". J. Immunol. 185, 7130 (2010).
38. Wei, J. et al. Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 104, 18169-18174 (2007).
39. Mantel, P.Y. et al. GATA3-driven Th2 responses inhibit TGF-β1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol. 5, e329 (2007).
40. Zheng, Y. et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808-812 (2010).
41. Selvaraj, R.K. & Geiger, T.L. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-β. J. Immunol. 178, 7667-7677 (2007).
42. Chen, Q., Kim, Y.C., Laurence, A., Punkosdy, G.A. & Shevach, E.M. IL-2 controls the stability of Foxp3 expression in TGF-β-induced Foxp3+ T cells in vivo. J. Immunol. 186, 6329-6337 (2011).
43. Liao, W. et al. Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor α-chain expression. Nat. Immunol. 9, 1288-1296 (2008).
44. Jonk, L.J., Itoh, S., Heldin, C.H., ten Dijke, P. & Kruijer, W. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer. J. Biol. Chem. 273, 21145-21152 (1998).
45. Liang, Q. et al. IL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-β and IL-10 in asthma. J. Immunol. 185, 5704-5713 (2010).
46. Wang, J., Ioan-Facsinay, A., van der Voort, E.I., Huizinga, T.W. & Toes, R.E. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur. J. Immunol. 37, 129-138 (2007).
47. Ramsdell, F., Jenkins, M., Dinh, Q. & Fowlkes, B.J. The majority of CD4+CD8thymocytes are functionally immature. J. Immunol. 147, 1779-1785 (1991).
48. Cote-Sierra, J. et al. Interleukin-2 plays a central role in Th2 differentiation. Proc. Natl. Acad. Sci. USA 101, 3880-3885 (2004).
49. Li, B., Tournier, C., Davis, R.J. & Flavell, R.A. Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J. 18, 420-432 (1999).
50. Park, J., Kim, S.H., Li, Q., Chang, Y.T. & Kim, T.S. Inhibition of interleukin-4 production in activated T cells via the downregulation of AP-1/NF-AT activation by N-lauroyl-d-erythro-sphingosine and N-lauroyl-d-erythro-C20-sphingosine. Biochem. Pharmacol. 71, 1229-1239 (2006).